Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.216 EUR | -1.82% | -3.57% | -82.78% |
Apr. 22 | Mithra Pharmaceuticals Obtains Court Protection Measures | MT |
Mar. 08 | Mithra Pharmaceuticals SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2023 | 40.16M 42.93M | Sales 2024 * | 43.9M 46.94M | Capitalization | 14.93M 15.96M |
---|---|---|---|---|---|
Net income 2023 | -174M -186M | Net income 2024 * | -55M -58.81M | EV / Sales 2023 | 9.88 x |
Net Debt 2023 | 310M 332M | Net Debt 2024 * | 166M 178M | EV / Sales 2024 * | 4.13 x |
P/E ratio 2023 * |
-0.16
x | P/E ratio 2024 * |
-
| Employees | 270 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 81.67% |
1 day | -1.82% | ||
1 week | -3.57% | ||
Current month | -22.58% | ||
1 month | -22.72% | ||
3 months | -80.75% | ||
6 months | -82.41% | ||
Current year | -82.78% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 17-02-22 | |
Stijn Vlaminck
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-30 |
Graham Dixon
CTO | Chief Tech/Sci/R&D Officer | 63 | 19-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jacques Galloy
BRD | Director/Board Member | 53 | 23-05-28 |
Christian Homsy
CHM | Chairman | 65 | 23-05-28 |
Valérie Gordenne
BRD | Director/Board Member | 51 | 21-05-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.216 | -1.82% | 82,336 |
24-04-25 | 0.22 | -0.68% | 113,992 |
24-04-24 | 0.2215 | -2.42% | 17,523 |
24-04-23 | 0.227 | +2.48% | 44,805 |
24-04-22 | 0.2215 | -1.12% | 120,811 |
Real-time Euronext Bruxelles, April 26, 2024 at 11:35 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-82.78% | 16.29M | |
-4.66% | 87.53B | |
+1.32% | 40.42B | |
-19.27% | 29.48B | |
+57.86% | 25.43B | |
-17.69% | 11.49B | |
-43.00% | 11.3B | |
-9.14% | 11.1B | |
+5.24% | 8.75B | |
-8.42% | 7.99B |
- Stock Market
- Equities
- MITRA Stock